Katrina Albert

480 total citations
16 papers, 351 citations indexed

About

Katrina Albert is a scholar working on Cellular and Molecular Neuroscience, Neurology and Neurology. According to data from OpenAlex, Katrina Albert has authored 16 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 10 papers in Neurology and 4 papers in Neurology. Recurrent topics in Katrina Albert's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Nerve injury and regeneration (9 papers) and Neurological disorders and treatments (7 papers). Katrina Albert is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Nerve injury and regeneration (9 papers) and Neurological disorders and treatments (7 papers). Katrina Albert collaborates with scholars based in Finland, United States and United Kingdom. Katrina Albert's co-authors include Mikko Airavaara, Andrii Domanskyi, Merja H. Voutilainen, Piotr Chmielarz, Jenni E. Anttila, Julia Konovalova, Šárka Lehtonen, Ilmari Parkkinen, Brandon K. Harvey and Mari Savolainen and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Katrina Albert

14 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrina Albert Finland 11 198 151 104 54 46 16 351
Juliann D. Jaumotte United States 9 162 0.8× 109 0.7× 143 1.4× 53 1.0× 31 0.7× 15 351
Yanpeng Yuan China 10 150 0.8× 225 1.5× 192 1.8× 68 1.3× 30 0.7× 26 475
Siv Vingill United Kingdom 7 126 0.6× 153 1.0× 139 1.3× 37 0.7× 44 1.0× 8 300
Samuel Burke Canada 5 186 0.9× 269 1.8× 112 1.1× 53 1.0× 30 0.7× 6 403
Alexia Paucard France 10 199 1.0× 94 0.6× 163 1.6× 50 0.9× 29 0.6× 13 366
Roxana Mesias United States 9 152 0.8× 164 1.1× 147 1.4× 38 0.7× 94 2.0× 10 361
Gautam Wali Australia 12 169 0.9× 103 0.7× 119 1.1× 77 1.4× 50 1.1× 30 363
Ivan Rattray United Kingdom 11 240 1.2× 101 0.7× 228 2.2× 33 0.6× 24 0.5× 15 431
Tomoko Nihira Japan 10 193 1.0× 252 1.7× 174 1.7× 77 1.4× 30 0.7× 13 448
Franco L. Lombino Germany 10 132 0.7× 101 0.7× 123 1.2× 38 0.7× 95 2.1× 13 412

Countries citing papers authored by Katrina Albert

Since Specialization
Citations

This map shows the geographic impact of Katrina Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina Albert more than expected).

Fields of papers citing papers by Katrina Albert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina Albert. The network helps show where Katrina Albert may publish in the future.

Co-authorship network of co-authors of Katrina Albert

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina Albert. A scholar is included among the top collaborators of Katrina Albert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina Albert. Katrina Albert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Swier, Vicki J., Wanda Pfeifer, Katrina Albert, et al.. (2025). Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten disease. Nucleic Acids Research. 53(20).
2.
Ohtonen, Sohvi, Kelvin C. Luk, Luca Giudice, et al.. (2024). Uptake of alpha‐synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microglia. Glia. 73(1). 159–174. 3 indexed citations
3.
Albert, Katrina, et al.. (2024). Glial cell transplant for brain diseases: the supportive saviours?. SHILAP Revista de lepidopterología. 9(1).
4.
Albert, Katrina, et al.. (2022). Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study. Biomedicines. 10(10). 2649–2649. 8 indexed citations
5.
Albert, Katrina, Anne Panhelainen, Ave Eesmaa, et al.. (2021). Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo. Molecular Therapy. 29(9). 2821–2840. 27 indexed citations
6.
Albert, Katrina, et al.. (2021). Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia. International Journal of Molecular Sciences. 22(9). 4334–4334. 27 indexed citations
7.
Chmielarz, Piotr, Julia Konovalova, Katrina Albert, et al.. (2020). GDNF / RET Signaling Pathway Activation Eliminates Lewy Body Pathology in Midbrain Dopamine Neurons. Movement Disorders. 35(12). 2279–2289. 36 indexed citations
8.
Airavaara, Mikko, Ilmari Parkkinen, Julia Konovalova, et al.. (2020). Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models. Current Protocols in Neuroscience. 91(1). e88–e88. 41 indexed citations
9.
10.
11.
Anttila, Jenni E., Katrina Albert, Emily S. Wires, et al.. (2018). Post-stroke Intranasal (+)-Naloxone Delivery Reduces Microglial Activation and Improves Behavioral Recovery from Ischemic Injury. eNeuro. 5(2). ENEURO.0395–17.2018. 37 indexed citations
12.
Albert, Katrina, Merja H. Voutilainen, Andrii Domanskyi, et al.. (2018). Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson’s disease. Journal of Neuroscience Research. 97(3). 346–361. 24 indexed citations
13.
Savolainen, Mari, Katrina Albert, Mikko Airavaara, & Timo T. Myöhänen. (2017). Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson’s disease in young and adult mouse. Experimental Brain Research. 235(7). 2189–2202. 25 indexed citations
14.
Albert, Katrina, Merja H. Voutilainen, Andrii Domanskyi, & Mikko Airavaara. (2017). AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models. Genes. 8(2). 63–63. 49 indexed citations
15.
Penttinen, Anna‐Maija, Ilida Suleymanova, Katrina Albert, et al.. (2016). Characterization of a new low‐dose 6‐hydroxydopamine model of Parkinson's disease in rat. Journal of Neuroscience Research. 94(4). 318–328. 38 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juliann D. Jaumotte Breakdown of academic impact, for papers by Yanpeng Yuan Breakdown of academic impact, for papers by Siv Vingill Breakdown of academic impact, for papers by Samuel Burke Breakdown of academic impact, for papers by Alexia Paucard Breakdown of academic impact, for papers by Roxana Mesias Breakdown of academic impact, for papers by Gautam Wali Breakdown of academic impact, for papers by Ivan Rattray Breakdown of academic impact, for papers by Tomoko Nihira Breakdown of academic impact, for papers by Franco L. Lombino
Rankless by CCL
2026